Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-05-25

FDA Approved: OLMESARTAN MEDOXOMIL — Original Application (Glenmark Pharmaceuticals Inc., USA)

View source ↗

Summary

FDA approved a generic version of olmesartan medoxomil (ANDA 203281) from Glenmark Pharmaceuticals Inc., USA for the treatment of hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OLMESARTAN MEDOXOMIL (olmesartan medoxomil)

Snippet

ORIG AP for OLMESARTAN MEDOXOMIL (OLMESARTAN MEDOXOMIL)